MedTrace Logo

Ambu®AuraGain™ Versus I-gel® in Obese Patients

NCT03110393 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2018-01-08

No results posted yet for this study

Summary

The aim of this study is the randomized comparison of two laryngeal mask (Intersurgical i-gel® and Ambu®AuraGain™) in obese patients

Conditions

Interventions

DEVICE

Ambu AuraGain

Insert and intubation of an Ambu® AuraGain™ laryngeal mask

DEVICE

Intersurgical i-gel

Insert and intubation of an Intersurgical i-gel®

Sponsors & Collaborators

  • Schulthess Klinik

    lead OTHER

Principal Investigators

  • Berthold Berthold, MD · Schulthess Klinik

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-20
Primary Completion
2017-09-06
Completion
2017-09-06

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03110393 on ClinicalTrials.gov